Answers are grounded in this paper and cite their sources.
Cross-national research has consistently documented sociodemographic gradients in depression across European countries. Most comprehensive analyses, however, predate the COVID-19 pandemic and its far-reaching consequences for population mental health and social hardship. Using data from the European Social Survey Round 11 (ESS 11, collected in 2023–2024), the most recent wave to include a measure of depression (CES-D 8), we examined the social patterning of depressive symptoms across 22 EU countries and the UK (N = 39,645) using multilevel modelling with sample design weighting. We confirm findings from prior ESS rounds of consistent gender, age, and income gradients in depression, confirming their persistence in the post-pandemic period. Women reported higher depressive symptoms than men across all countries, and income emerged as the strongest individual-level predictor, with those in the lowest income tertile scoring on average 2.09 points higher on the CES-D 8 than those in the highest (the scale ranging from 0-24). Critically, these associations are not uniform across national contexts. The gender gap in depressive symptoms was larger in Southern European countries—particularly Portugal and Spain than in Northern and Eastern Europe, while the protective effect of higher income was strongest in Bulgaria, Hungary, Belgium, and Greece. Country context alone accounted for only a small proportion of total variance in depressive symptoms (ICC = 0.033), indicating that differences in depression at the population level are driven primarily by sociodemographic factors, but that their magnitude is meaningfully shaped by where people live.
No takes yet. Share an insight, caveat, or question.
Jarke et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: